CV Sciences Inc.

CV Sciences Inc.

At CV Sciences, our mission to improve well‐being underscores our values, operations, and products.
Biotechnology
1d 5d 1m 6m 1y Max

CV Sciences Inc. News

14 May

CV Sciences’ PlusCBD Oil™ Used in First Study Examining Clinical Benefit of CBD for Patients with PTSD

CV Sciences, Inc. (CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, is pleased to announced that its industry-dominating...

10 May

Edited Transcript of CVSI earnings conference call or presentation 8-May-19 8:30pm GMT

Q1 2019 CV Sciences Inc Earnings Call

08 May

CV Sciences, Inc. Reports First Quarter 2019 Financial Results

Record quarterly revenue Increased retail distribution by over 1,000 stores LAS VEGAS, May 08, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) ("CV Sciences" or the “Company”).

07 May

CV Sciences, Inc. to Present at Upcoming Investor Conferences

LAS VEGAS, May 07, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) a preeminent supplier and manufacturer of hemp CBD products.

01 May

CV Sciences, Inc. (CVSI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

CV Sciences, Inc. (CVSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

30 Apr

There is No Slowdown Ahead for CBD Growth in 2019

Not only has it transformed multi-billion-dollar industries including alcohol, health and wellness, cigarettes, and the retail industry, it's impacting food, too. Better, the U.S. FDA could provide a...

30 Apr

CV Sciences, Inc. to Announce First Quarter 2019 Results on May 8, 2019

CV Sciences, Inc. (CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced that it will release financial results for its first quarter 2019 ended March 31, 2019, after the stock market closes...

23 Apr

With Strong Demand, More Top Retailers are Just Beginning to Sell CBD Products

Neiman Marcus is pushing ahead with CBD sales at some of its stores and online. Simon Property Group is partnering with Green Growth Brands to open 108 stores in its malls just in 2019. CVS will carry...

15 Apr

CV Sciences, Inc. Appoints Deloitte & Touche LLP as Auditor

LAS VEGAS, April 15, 2019 -- CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products,.

12 Apr

Three Companies Giving Investor the Biggest Exposure to CBD Growth

HOUSTON, TX / ACCESSWIRE / April 12, 2019 / According to the Brightfield Group, worldwide CBD sales are expected to soar from $591 million in 2018 to as high as $22 billion by 2022 - a compound growth...

Load more

About CV Sciences Inc.

CV Sciences, Inc., a life sciences organization, is focused on promoting healthy living through their pharmaceutical drug development efforts and portfolio of finished product brands. CV Sciences’ Pharmaceutical Division is developing synthetically‐formulated cannabidiol‐based medicine, pursuing the approval of the U.S. Food and Drug Administration (FDA) for drugs with specific indications utilizing cannabidiol as the active pharmaceutical ingredient. CV Sciences’ Consumer Products Division delivers botanical‐based cannabidiol products

Participation in events

$ 4.86
0.41%
Open:
4.87
High:
5.03
Low:
4.81
Share volume:
523.812 K
Total value:
2.593 M
Market cap:
479.472 M
Symbol:
CVSI